Metagenomi Therapeutics, Inc. (MGX)
1.52
+0.05
(+3.40%)
USD |
NASDAQ |
Feb 19, 16:00
1.54
+0.02
(+1.32%)
Pre-Market: 20:00
Metagenomi Therapeutics Market Cap : 57.07M for Feb. 19, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 4.116B |
| Agenus, Inc. | 116.01M |
| Alnylam Pharmaceuticals, Inc. | 45.01B |
| Savara, Inc. | 1.164B |
| Arrowhead Pharmaceuticals, Inc. | 8.942B |
Market Cap Related Metrics
| PS Ratio | 1.831 |
| Price to Book Value | 0.3198 |
| Price | 1.52 |
| Earnings Yield | -156.8% |